Ellington Management Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-7,404
Closed -$300K 700
2019
Q4
$300K Buy
+7,404
New +$276K 0.06% 307
2019
Q3
Sell
-18,300
Closed -$580K 738
2019
Q2
$580K Buy
+18,300
New +$544K 0.1% 200
2017
Q4
Sell
-13,500
Closed -$676K 764
2017
Q3
$676K Buy
+13,500
New +$690K 0.12% 129
2017
Q2
Sell
-15,300
Closed -$850K 843
2017
Q1
$850K Buy
+15,300
New +$844K 0.03% 133
2014
Q2
Sell
-10,200
Closed -$278K 609
2014
Q1
$278K Buy
+10,200
New +$303K 0.08% 390
2013
Q3
Sell
-16,900
Closed -$492K 923
2013
Q2
$492K Buy
+16,900
New +$476K 0.09% 316

Other funds holding PBH

Ellington Management Group's PBH Position: Q1 2020 in Review

Ellington Management Group sold out of Prestige Consumer Healthcare (PBH) in Q1 2020, closing a stake of 7,404 shares — an estimated $300K sold.

Ellington Management Group first reported a position in PBH in Q2 2013 and held it in 6 quarters. The position peaked at $850K in Q1 2017. 251 funds tracked by Wall St. Rank hold PBH as of Q1 2020.

  • Ellington Management Group reported no remaining Prestige Consumer Healthcare position as of Q1 2020 after selling out during the quarter.
  • Ellington Management Group sold 7,404 Prestige Consumer Healthcare shares in Q1 2020, an estimated $300K.
  • Ellington Management Group first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 6 quarters.
  • Ellington Management Group's Prestige Consumer Healthcare position peaked at $850K in Q1 2017.
  • 251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2020.

Based on Ellington Management Group's 13F filing for Q1 2020, filed 15 May 2020.